Skip to main content

Educational content only. Not a substitute for medical advice. Always consult a qualified clinician.

Getting started

What is a research blend?

A research blend is a fixed-ratio combination of two or more peptides supplied together in a single vial — combining complementary mechanisms into one preparation.

Last reviewed 2026-07-13

Read the answer

A research blend is a peptide product in which two or more distinct peptides are supplied together in the same vial at a fixed ratio, designed to be reconstituted and administered as a single preparation. Blends are a first-class content type in this catalog — Aura (GHK-Cu + BPC-157 + KPV), Glow (GHK-Cu + BPC-157 + TB-500), Klow (all four), CJC-1295 + Ipamorelin, BPC-157 + TB-500, Tesamorelin + Ipamorelin, and Selank + Semax.

The pharmacological logic of a blend is that different peptides address different layers of the same physiological process, and combining them can produce complementary rather than overlapping effects. In tissue-repair blends, GHK-Cu addresses gene expression, BPC-157 addresses vascular supply and fibroblast recruitment, TB-500 addresses cellular migration, and KPV lowers the inflammatory background. In GH-secretagogue blends, GHRH-analogues (CJC-1295, Tesamorelin) engage one receptor system on pituitary somatotrophs and ghrelin-mimetics (Ipamorelin) engage another — the combination produces greater GH release than either alone.

Importantly, blend-level clinical evidence generally does not exist. The evidence base is component-level: what we know is that each peptide in a blend has some individual research history, and the combination inherits and layers those individual profiles. When reading blend content, treat mechanistic claims as combinations of the individual peptides' claims rather than as separately validated blend-level effects.

Question

Other questions that touch the same biology, evidence, or laboratory concepts.